Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity (original) (raw)

• Beal M. F., Ferrante R. J., Henshaw R., et al. (1995) 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 65, 919–922.
  Article PubMed CAS Google Scholar
• Beal M. F., Matson W. R., Storey E., et al. (1992) Kynurenic acid concentrations are reduced in Huntington’s disease cerebral cortex. J. Neurol. Sci. 108, 80–87.
  Article PubMed CAS Google Scholar
• Beal M. F., Matson W. R., Swartz K. J., Gamache P. H., and Bird E. D. (1990) Kynurenine pathway measurements in Huntington’s disease striatum: evidence for reduced formation of kynurenic acid. J. Neurochem. 55, 1327–1339.
  Article PubMed CAS Google Scholar
• Chang J. G., Hsieh-Li H. M., Jong Y. J., Wang N. M., Tsai C. H., and Li H. (2001) Treatment of spinal muscular atrophy by sodium butyrate. Proc. Natl. Acad. Sci. USA 98, 9808–9813.
  Article PubMed CAS Google Scholar
• Corcoran L. J., Mitchison T. J., and Liu Q. (2004) Anovel action of histone deacetylase inhibitors in a protein aggresome disease model. Curr. Biol. 14, 488–492.
  Article PubMed CAS Google Scholar
• Czubryt M. P., McAnally J., Fishman G. I., and Olson E. N. (2003) Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc. Natl. Acad. Sci. USA 100, 1711–1716.
  Article PubMed CAS Google Scholar
• Ferrante R. J., Kubilus J. K., Lee J., et al. (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington’s disease mice. J. Neurosci. 23, 9418–9427.
  PubMed CAS Google Scholar
• Hockly E., Richon V. M., Woodman B., et al. (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington’s disease. Proc. Natl. Acad. Sci. USA 100, 2041–2046.
  Article PubMed CAS Google Scholar
• Jeong M. R., Hashimoto R., Senatorov V. V., et al. (2003) Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. FEBS Lett. 542, 74–78.
  Article PubMed CAS Google Scholar
• Kaeberlein M., McVey M., and Guarente L. (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Gene Dev. 13, 2570–2580.
  Article PubMed CAS Google Scholar
• Kang H. L., Benzer S., and Min K. T. (2002) Life extension in Drosophila by feeding a drug. Proc. Natl. Acad. Sci. USA 99, 838–843.
  Article PubMed CAS Google Scholar
• Leoni F., Zaliani A., Bertolini G., et al. (2002) The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc. Natl. Acad. Sci. USA 99, 2995–3000.
  Article PubMed CAS Google Scholar
• Maehara K., Uekawa N., and Isobe K. (2002) Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene. Biochem. Biophys. Res. Comm. 295, 187–192.
  Article CAS Google Scholar
• McCampbell A., Taye A. A., Whitty L., Penney E., Steffan J. S., and Fischbeck K. H. (2001) Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc. Natl. Acad. Sci. USA 98, 15,179–15,184.
  Article CAS Google Scholar
• McGuinness M. C., Lu J. F., Zhang H. P., et al. (2003) Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy. Mol. Cell Biol. 23, 744–753.
  Article PubMed CAS Google Scholar
• McKinsey T. A., Zhang C. L., and Olson E. N. (2000) Activation of myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deactylase 5. Proc. Natl. Acad. Sci. USA 97, 14400–14405.
  Article PubMed CAS Google Scholar
• Minamiyama M., Katsuno M., Adachi H., et al. (2004) Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 13, 1183–1192.
  Article PubMed CAS Google Scholar
• Naya F. J., Black B. L., Wu H., et al. (2002) Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat. Med. 8, 1303–1309.
  Article PubMed CAS Google Scholar
• Onyango P., Celic I., McCaffery M., et al. (2002) SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc. Natl. Acad. Sci. USA 99, 13653–13658.
  Article PubMed CAS Google Scholar
• Puigserver P. and Spiegelman B. M. (2003) Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24, 78–90.
  Article PubMed CAS Google Scholar
• Ryu H., Lee J., Olofsson B. A., et al. (2003) Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc. Natl. Acad. Sci. USA 100, 4281–4286.
  Article PubMed CAS Google Scholar
• Schulz J. B., Henshaw D. R., MacGarvey U., and Beal, M. F. (1996) Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity. Neurochem. Int. 29, 167–171.
  Article PubMed CAS Google Scholar
• Steffan J. S., Bodai L., Pallos J., et al. (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413, 739–743.
  Article PubMed CAS Google Scholar
• Tissenbaum H. A. and Guarente L. (2001) Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410, 227–230.
  Article PubMed CAS Google Scholar
• Wu H., Kanatous S. B., Thurmond F. A., et al. (2002) Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296, 349–352.
  Article PubMed CAS Google Scholar
• Youn H. D., Grozinger C. M., and Liu J. O. (2000) Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4. J. Biol. Chem. 275, 22,563–22,567.
  Article CAS Google Scholar